Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?

The process of discovery of 18 important adverse drug reactions was reviewed. For each adverse reaction the dates were noted of the report which first alerted the medical profession to the suspected reaction, the report which resulted in verification of causality beyond reasonable doubt, and the first regulatory action or warning to the medical profession in Britain by the Committee on the Safety of Medicines.

[1]  J. Smadel Chloramphenicol (chloromycetin) in the treatment of infectious diseases , 1949 .

[2]  I. Greenspan,et al.  Hemopoietic changes during administration of chloramphenicol (chloromycetin). , 1950, Journal of the American Medical Association.

[3]  R. Ritterhoff,et al.  A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. , 1950, Annals of internal medicine.

[4]  D. Karnofsky,et al.  Effects of large doses of chloramphenicol on human subjects. , 1955, The New England journal of medicine.

[5]  L. Hensler,et al.  Die chronisch-interstitielle Nephritis , 1957 .

[6]  L. Vandam,et al.  ANESTHETIC, CIRCULATORY AND RESPIRATORY EFFECTS OF FLUOTHANE , 1958, Anesthesiology.

[7]  A. Linton,et al.  Phenethyldiguanide: a dangerous side-effect. , 1959, British medical journal.

[8]  K. Larsen,et al.  A renal lesion caused by abuse of phenacetin. , 2009, Acta medica Scandinavica.

[9]  M. Samrah Liver Damage After Halothane , 1963, British medical journal.

[10]  J. Fawcett,et al.  CORONARY THROMBOSIS AND CONOVID , 1963 .

[11]  J. Graham METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS. , 1964, The New England journal of medicine.

[12]  D. J. Finney THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE. , 1965, Journal of chronic diseases.

[13]  H. Tsukagoshi,et al.  Subacute Myelo-Optico-Neuropathy Following Abdominal Symptoms , 1965 .

[14]  Summary of the national Halothane Study. Possible association between halothane anesthesia and postoperative hepatic necrosis. , 1966, JAMA.

[15]  N. Sadowsky,et al.  Fibrotic disorders associated with methysergide therapy for headache. , 1966, The New England journal of medicine.

[16]  J. Brooks-Gunn Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee. , 1967, British medical journal.

[17]  W. Inman,et al.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. , 1968, British medical journal.

[18]  A M Adelstein,et al.  Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. , 1969, Lancet.

[19]  G. Klatskin,et al.  Recurrent hepatitis attributable to halothane sensitization in an anesthetist. , 1970, The New England journal of medicine.

[20]  W. Inman,et al.  Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs , 1970, British medical journal.

[21]  R. Scully,et al.  Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). , 1970, Cancer.

[22]  A. Herbst,et al.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. , 1971, The New England journal of medicine.

[23]  T. Tsubaki,et al.  Neurological syndrome associated with clioquinol. , 1971, Lancet.

[24]  R. Scully,et al.  Clear-cell adenocarcinoma of the genital tract in young females. Registry report. , 1972, The New England journal of medicine.

[25]  P. Stolley Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. , 1972, The American review of respiratory disease.

[26]  J. S. Comaish,et al.  The value of patch and other skin tests in drug eruptions. , 1974, Lancet.

[27]  R. Felix,et al.  Cutaneous and Ocular Reactions to Practolol , 1974, British medical journal.

[28]  F. W. Hehre "Halothane hepatitis". , 1974, Connecticut medicine.

[29]  W. Inman,et al.  Oral contraceptives and death from myocardial infarction. , 1975, British medical journal.

[30]  M. Thorogood,et al.  Myocardial infarction in young women with special reference to oral contraceptive practice. , 1975, British medical journal.

[31]  T. Meade Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis. , 1975, British journal of preventive & social medicine.

[32]  P. Wright Untoward effects associated with practolol administration: oculomucocutaneous syndrome. , 1975, British medical journal.

[33]  R. Peto,et al.  CONTROLLED TRIAL OF REPEATED HALOTHANE ANAESTHETICS IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIX TREATED WITH RADIUM , 1975 .

[34]  R. Doll,et al.  FREQUENCY OF EYE COMPLAINTS AND RASHES AMONG PATIENTS RECEIVING PRACTOLOL AND PROPRANOLOL , 1977, The Lancet.

[35]  A. Read Practolol peritonitis , 1977, Clinical radiology.

[36]  R. Doll,et al.  The case for recording events in clinical trials. , 1977, British medical journal.

[37]  M. Rawlins Pathogenesis of adverse drug reactions , 1977 .

[38]  V. Beral,et al.  Randomised trial of high doses of stilboestrol and ethisterone therapy in pregnancy: long-term follow-up of the children. , 1981, Journal of epidemiology and community health.

[39]  J. Deacon DEATH FROM ASTHMA , 1980, The Medical journal of Australia.